Reuters logo
BRIEF-Peregrine Pharmaceuticals presents preliminary correlative analysis of PD-l1 expression from sunrise trial
2017年6月5日 / 下午1点52分 / 6 个月前

BRIEF-Peregrine Pharmaceuticals presents preliminary correlative analysis of PD-l1 expression from sunrise trial

June 5 (Reuters) - Peregrine Pharmaceuticals Inc

* Peregrine Pharmaceuticals presents preliminary correlative analysis of pd-l1 expression from sunrise trial at asco 2017

* Peregrine Pharmaceuticals Inc - ‍results support hypothesis that bavituximab may demonstrate greater effect in “cold” tumors expressing low to no pd-l1​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below